Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom
A 2-dose regimen of the vaccine modified vaccinia Ankara-Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for monkeypox virus clade Ib as well as for clade IIb.
Authors
- Victoria Sheridan
- Craig W. Duffy (ORCID: https://orcid.org/0000-0001-9359-4888)
- Lance Turtle
- Julian A. Hiscox
- on behalf of the ISARIC4C Investigators
- Krishanthi S. Subramaniam
- Jake Dunning
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2026-02-01
- DOI
- https://doi.org/10.3201/eid3202.251553
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00